Skip to main content
placeholder image

Pooled analysis of phase I dose-escalation and dose cohort expansion studies of IMP4297, a novel PARP inhibitor, in Chinese and Australian patients with advanced solid tumors.

Journal Article


Abstract


UOW Authors


  •   De Souza, Paul (external author)

Publication Date


  • 2019

Citation


  • Cao, J., Zhang, P., de Souza, P. L., Gao, B., Voskoboynik, M., Ji, D., . . . Xu, B. (2019). Pooled analysis of phase I dose-escalation and dose cohort expansion studies of IMP4297, a novel PARP inhibitor, in Chinese and Australian patients with advanced solid tumors.. Journal of Clinical Oncology, 37(15_suppl), 3059. doi:10.1200/jco.2019.37.15_suppl.3059

Web Of Science Accession Number


Start Page


  • 3059

End Page


  • 3059

Volume


  • 37

Issue


  • 15_suppl

Place Of Publication


Abstract


UOW Authors


  •   De Souza, Paul (external author)

Publication Date


  • 2019

Citation


  • Cao, J., Zhang, P., de Souza, P. L., Gao, B., Voskoboynik, M., Ji, D., . . . Xu, B. (2019). Pooled analysis of phase I dose-escalation and dose cohort expansion studies of IMP4297, a novel PARP inhibitor, in Chinese and Australian patients with advanced solid tumors.. Journal of Clinical Oncology, 37(15_suppl), 3059. doi:10.1200/jco.2019.37.15_suppl.3059

Web Of Science Accession Number


Start Page


  • 3059

End Page


  • 3059

Volume


  • 37

Issue


  • 15_suppl

Place Of Publication